Search Medical Condition
Please enter condition
Please choose location from dropdown

Sexual Dysfunction Clinical Trials

A listing of Sexual Dysfunction medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (104) clinical trials

A woman's sexual desires naturally fluctuate over the years. Highs and lows commonly coincide with the beginning or end of a relationship or with major life changes, such as pregnancy, menopause or illness. Some antidepressants and anti-seizure medications also can cause low sex drive in women. If you have a ...

Phase N/A

Vaginal atrophy, also called (Vaginal Dryness/Irritation/Painful Intercourse), is thinning, drying and inflammation of the vaginal walls due to your body having less estrogen. Vaginal atrophy occurs most often after menopause. For many women, vaginal atrophy makes intercourse painful — and if intercourse hurts, your interest in sex will naturally decrease. ...

Phase N/A

If you’re a woman at least 30 years of age, have had a hysterectomy, and are experiencing a decrease in sexual desire, you may qualify for medical research study. The study will evaluate LibiGel®, an investigational, medication for Hypoactive Sexual Desire Disorder (HSSD). Local physicians are enrolling participants now. All ...

Phase

The objective of this study is to confirm the efficacy of intravaginal DHEA (also named prasterone) on Hypoactive Sexual Desire Disorder (HSDD) in postmenopausal women. We will also evaluate the effects of study treatment on the number of satisfying (pleasing) sexual events (SSEs). This study will last 28 weeks and ...

Phase

The purpose of this research study is to determine if pelvic floor therapy is effective in treating pain related sexual dysfunction. We are interested in examining pelvic floor therapy (a type of gynecologic physical therapy) as an intervention for sexual dysfunction.  

Phase N/A

Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized Controlled Double Blind Trial

The proposed mechanism of action for LI-ESWT in ED is that it improves endothelial function and triggers angiogenesis through induction of local growth factors and endothelial nitric oxide synthase. The literature generally confirms that LI-ESWT is safe and cohort studies investigating the clinical effects have been encouraging. Meanwhile, randomized trials ...

Phase N/A

Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.

Female lower urinary tract dysfunction includes stress urinary incontinence, overactive bladder syndrome and voiding dysfunction. There are a lot of bladder studies, such as researches of bladder wall thickness and bladder volume. However, there were few studies of urethra for female patients with lower urinary tract symptoms (LUTS), especially for ...

Phase N/A

Injectable Collagen Scaffold Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes

The intent of this clinical study is to answer the questions: 1) is the proposed treatment feasible; 2) is treatment effective in improving the disease pathology of patients with diagnosed diabetic erectile dysfunction.

Phase

Stem Cell Therapy Combined With NeuroRegen Scaffold in Patients With Erectile Dysfunction After Rectal Cancer Surgery

Erectile dysfunction (ED) is one of the commonest complications in men after rectal cancer treatment. The purpose of this study is to assess the safety and efficacy of autologous bone marrow mononuclear cells (BMMCs) or allogeneic human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) combined with NeuroRegen scaffold transplantation in men ...

Phase

Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women

Introduction The daily application of estrogen in the vagina can improve the hydrogen potential (pH), vaginal dryness, burning sensation, dyspareunia, and urinary symptoms. Dyspareunia is highly prevalent after menopause as well as in women after gynecological and breast cancer treatment. However, prescription of topical estrogen therapy (THT) to these women ...

Phase